For example, the ADC Trastuzumab emtansine (T-DM1) consists of trastuzumab, an antibody targeting tumour cells overexpressing the human epidermal growth factor 2 (HER2), linked with the antimitotic agent emtansine (DM1). Here, ERBB2 is linked to neoplasm.